Terms: = Prostate cancer AND PSA AND Diagnosis
5151 results:
1. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
[TBL] [Abstract] [Full Text] [Related]
2. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.
Tang Y; Gao Y; Zhang R; Li T; Yang Y; Huang L; Wei Y
Sci Rep; 2024 Apr; 14(1):9494. PubMed ID: 38664545
[TBL] [Abstract] [Full Text] [Related]
3. [prostate cancer - a disease in transformation].
Bratt O
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38661575
[TBL] [Abstract] [Full Text] [Related]
4. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized prostate cancer.
Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
[TBL] [Abstract] [Full Text] [Related]
5. [Study on the length and quality of prostate biopsy tissue strips].
Geng YS; Gao YQ; Cao FH; Wu S; Ding XF
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):1000-1005. PubMed ID: 38639952
[TBL] [Abstract] [Full Text] [Related]
6. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
[TBL] [Abstract] [Full Text] [Related]
7. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
8. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
[TBL] [Abstract] [Full Text] [Related]
10. [Difference between prostate cancer patients' Gleason scores from preoperative biopsy and those from postoperative pathology].
Zhao XD; Liu YH; Hu J; Wang ZH; Jin XX; Ma MF; Zhou YL; Chen YH; Cao J; Dong J; Xu S
Zhonghua Nan Ke Xue; 2023 May; 29(5):393-401. PubMed ID: 38602754
[TBL] [Abstract] [Full Text] [Related]
11. Predictive Value of Magnetic Resonance Imaging Radiomics Combined with Serum psa for the Extracapsular Extension of prostate cancer Prediction.
Wu J; Yu X; Zuo Z; Li J; Du F; Wang P; Jiang R
Arch Esp Urol; 2024 Mar; 77(2):217-223. PubMed ID: 38583015
[TBL] [Abstract] [Full Text] [Related]
12. Is Unilateral Lymphadenectomy an Option in Selected Patients with prostate cancer?
Kassab BN; De Pablos-Rodríguez P; Ferrer ÁG; García AC; Fons AC; Aragón F; Ramón-Borja JC; Ramírez-Backhaus M
Arch Esp Urol; 2024 Mar; 77(2):129-134. PubMed ID: 38583004
[TBL] [Abstract] [Full Text] [Related]
13. prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey.
Harmatz IM; Alkhatib KY; Leff M; Nolazco JI; Michel KF; Slinger M; McLauchlan N; Cortese BD; Roberson DS; Schurhamer B; Lee DJ; Malkowicz SB; Trinh QD; Bivalacqua TJ; Guzzo TJ; Pierorazio PM
Urol Pract; 2024 May; 11(3):547-556. PubMed ID: 38564816
[TBL] [Abstract] [Full Text] [Related]
14. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
[TBL] [Abstract] [Full Text] [Related]
15. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
[TBL] [Abstract] [Full Text] [Related]
16. Exosomal prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of prostate cancer-Evidence from Serbian Population.
Matijašević Joković S; Korać A; Kovačević S; Djordjević A; Filipović L; Dobrijević Z; Brkušanin M; Savić-Pavićević D; Vuković I; Popović M; Brajušković G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542507
[TBL] [Abstract] [Full Text] [Related]
17. Machine-learning Algorithm-based Risk Prediction and Screening-detected prostate cancer in A Benign prostate Hyperplasia Cohort.
Chang CC; Chiou JK; Lin CJ; Lu K; Li JR; Chang LW; Hung SC; Cheng CL
Anticancer Res; 2024 Apr; 44(4):1683-1693. PubMed ID: 38537959
[TBL] [Abstract] [Full Text] [Related]
18. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
19. Testicular metastasis of prostate adenocarcinoma: the other side of orchiepididymitis.
Di Rienzo G; Tafuni A; Maestroni U; Ruffini L; Silini EM; Gasparro D; Pilato FP; Gnetti L
Pathologica; 2024 Feb; 116(1):69-74. PubMed ID: 38482677
[TBL] [Abstract] [Full Text] [Related]
20. Different diagnostic strategies combining prostate health index and magnetic resonance imaging for predicting prostate cancer: A multicentre study.
Zhu M; Fu Q; Zang Y; Shao Z; Zhou Y; Jiang Z; Wang W; Shi B; Chen S; Zhu Y
Urol Oncol; 2024 May; 42(5):159.e17-159.e23. PubMed ID: 38480077
[TBL] [Abstract] [Full Text] [Related]
[Next]
